Department of Neurosurgery, Tel-Aviv Medical Center, Tel Aviv, Israel.
AJNR Am J Neuroradiol. 2011 Dec;32(11):2180-4. doi: 10.3174/ajnr.A2728. Epub 2011 Oct 13.
Intracranial DAVFs with cortical venous drainage have a high tendency to bleed. Complete closure of these lesions is essential to prevent clinically deleterious events. We describe our experience using Onyx in an arterial approach for treatment of DAVFs in 17 patients.
Between 2006 and 2010, we used Onyx for performing transarterial embolization in 17 patients with intracranial DAVFs and cortical venous drainage. Clinical assessment was performed before and after every treatment at discharge and at follow-up. Fourteen patients underwent follow-up MR imaging and MRA, 8 of them also underwent follow-up diagnostic angiography.
Fifteen patients (88%) underwent 1 procedure. Complete obliteration by embolization with Onyx was achieved in 16 patients (94% acute obliteration). The mean amount of Onyx injected was 2.3 mL (range, 0.4-4.8 mL). The sole technical complication was an embolus to a branch of the MCA, which was resolved by intra-arterial tPA injection. A clinical complication of transient trochlear nerve palsy in the same patient due to mass effect of Onyx resolved spontaneously within 3 months.
Intra-arterial embolization of cranial DAVFs with cortical venous drainage by using Onyx results in a high rate of complete obliteration (94%) with low morbidity (6%). Follow-up DSA in 8 patients revealed no evidence of reopening.
具有皮质静脉引流的颅内 DAVF 出血倾向较高。为了预防临床有害事件,必须完全闭塞这些病变。我们描述了我们使用 Onyx 通过动脉入路治疗 17 例 DAVF 的经验。
在 2006 年至 2010 年期间,我们使用 Onyx 对 17 例具有颅内 DAVF 和皮质静脉引流的患者进行了经动脉栓塞治疗。在每次治疗前后出院时和随访时进行临床评估。14 例患者接受了随访性磁共振成像和 MRA,其中 8 例还接受了随访性诊断性血管造影。
15 例患者(88%)进行了 1 次治疗。16 例患者(94%)通过 Onyx 栓塞完全闭塞。Onyx 的平均注射量为 2.3mL(范围,0.4-4.8mL)。唯一的技术并发症是 MCA 分支的栓子,通过动脉内 tPA 注射解决。同一患者由于 Onyx 的占位效应导致的短暂滑车神经麻痹的临床并发症在 3 个月内自发缓解。
使用 Onyx 通过动脉栓塞治疗具有皮质静脉引流的颅 DAVF 可实现高完全闭塞率(94%)和低发病率(6%)。8 例患者的随访 DSA 未显示再通证据。